Insider holders · CIK 0001428522
Radius Health, Inc. · RDUS
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Growth N Biotech V10% Owner | 6,781,685 | — | 6,781,685 | Feb 19, 2019 · 11:04 am EST | Form 4 |
| BB BIOTECH AG10% Owner | 6,781,685 | — | 6,781,685 | Feb 19, 2019 · 11:04 am EST | Form 4 |
| Luke Evninrelationship not stated | — | 3,887,502 | 3,887,502 | Sep 29, 2016 · 6:05 pm EDT | Form 4 |
| Ansbert GadickeDirector | — | 3,887,502 | 3,887,502 | Sep 29, 2016 · 6:05 pm EDT | Form 4 |
| Globeways Holdings Ltd10% Owner | 1,794,983 | 871,851 | 2,666,834 | Jan 15, 2015 · 5:04 pm EST | Form 4 |
| F2 Bio Ventures GP Ltd.10% Owner | 1,794,983 | 871,851 | 2,666,834 | Jan 15, 2015 · 5:04 pm EST | Form 4 |
| F2 Bio Ventures V L.P.10% Owner | 1,794,983 | 871,851 | 2,666,834 | Jan 15, 2015 · 5:04 pm EST | Form 4 |
| F2 Bioscience IV GP Ltd.10% Owner | 1,794,983 | 871,851 | 2,666,834 | Jan 15, 2015 · 5:04 pm EST | Form 4 |
| F2 Bioscience IV L.P.10% Owner | 1,794,983 | 871,851 | 2,666,834 | Jan 15, 2015 · 5:04 pm EST | Form 4 |
| F2 Capital Ltd10% Owner | 1,794,983 | 871,851 | 2,666,834 | Jan 15, 2015 · 5:04 pm EST | Form 4 |
| Katherine Priestley10% Owner | 1,794,983 | 871,851 | 2,666,834 | Jan 15, 2015 · 5:04 pm EST | Form 4 |
| Kurt Wheelerrelationship not stated | — | 2,459,804 | 2,459,804 | Sep 29, 2016 · 6:04 pm EDT | Form 4 |
| Nicholas Galakatosrelationship not stated | — | 2,459,804 | 2,459,804 | Sep 29, 2016 · 6:04 pm EDT | Form 4 |
| Dennis Hennerrelationship not stated | — | 2,459,804 | 2,459,804 | Sep 29, 2016 · 6:04 pm EDT | Form 4 |
| MPM BIOVENTURES III LLCrelationship not stated | — | 2,459,804 | 2,459,804 | Sep 29, 2016 · 6:04 pm EDT | Form 4 |
| MPM BIOVENTURES III GP L.P.relationship not stated | — | 2,459,804 | 2,459,804 | Sep 29, 2016 · 6:04 pm EDT | Form 4 |
| MPM ASSET MANAGEMENT INVESTORS 2003 BVIII LLCrelationship not stated | — | 2,459,804 | 2,459,804 | Sep 29, 2016 · 6:04 pm EDT | Form 4 |
| MPM BIOVENTURES III GMBH & CO. Beteiligungs KGrelationship not stated | — | 2,459,804 | 2,459,804 | Sep 29, 2016 · 6:04 pm EDT | Form 4 |
| MPM BIOVENTURES III PARALLEL FUND, L.P.relationship not stated | — | 2,459,804 | 2,459,804 | Sep 29, 2016 · 6:04 pm EDT | Form 4 |
| Nicholas J Simon IIIrelationship not stated | — | 2,459,804 | 2,459,804 | Sep 29, 2016 · 6:04 pm EDT | Form 4 |
| MPM BIOVENTURES III-QP L.P.relationship not stated | — | 2,459,804 | 2,459,804 | Sep 29, 2016 · 6:04 pm EDT | Form 4 |
| MPM BIOVENTURES III L.P.relationship not stated | — | 2,459,804 | 2,459,804 | Sep 29, 2016 · 6:04 pm EDT | Form 4 |
| Michael Steinmetzrelationship not stated | — | 2,459,804 | 2,459,804 | Sep 29, 2016 · 6:04 pm EDT | Form 4 |
| Todd Foleyrelationship not stated | — | 1,427,698 | 1,427,698 | Sep 29, 2016 · 6:03 pm EDT | Form 4 |
| MPM Bio IV NVS Strategic Fund LPrelationship not stated | — | 1,427,698 | 1,427,698 | Sep 29, 2016 · 6:03 pm EDT | Form 4 |
| MPM BioVentures IV LLCrelationship not stated | — | 1,427,698 | 1,427,698 | Sep 29, 2016 · 6:03 pm EDT | Form 4 |
| MPM BioVentures IV GP LLCrelationship not stated | — | 1,427,698 | 1,427,698 | Sep 29, 2016 · 6:03 pm EDT | Form 4 |
| James Paul Scoparelationship not stated | — | 1,427,698 | 1,427,698 | Sep 29, 2016 · 6:03 pm EDT | Form 4 |
| Vaughn M Kailianrelationship not stated | — | 1,427,698 | 1,427,698 | Sep 29, 2016 · 6:03 pm EDT | Form 4 |
| Morana Jovan-EmbiricosDirector | — | 871,851 | 871,851 | Jan 15, 2015 · 5:03 pm EST | Form 4 |
| Brian Nicholas HarveySr. VP and CFO | 76,189 | — | 76,189 | Apr 27, 2017 · 8:58 pm EDT | Form 4 |
| Jose CarmonaChief Financial Officer | 18,000 | — | 18,000 | Feb 26, 2019 · 6:21 pm EST | Form 4 |
| Brent Hatzis-SchochSr. VP, General Counsel | 17,944 | — | 17,944 | Feb 26, 2019 · 6:14 pm EST | Form 4 |
| Robert WardPresident & CEO | 15,000 | — | 15,000 | Oct 25, 2016 · 9:54 pm EDT | Form 4 |
| Charles Q MorrisChief Medical Officer | 15,000 | — | 15,000 | Feb 26, 2019 · 6:16 pm EST | Form 4 |
| Jesper HoeilandPresident and CEO | 13,567 | — | 13,567 | Feb 13, 2019 · 5:39 pm EST | Form 5 |
| Joseph Francis KellySr. VP of Sales and Marketing | 13,000 | — | 13,000 | Feb 26, 2019 · 6:16 pm EST | Form 4 |
| Jessica HopfieldDirector | 12,800 | — | 12,800 | Mar 6, 2019 · 4:29 pm EST | Form 4 |
| Debasish RoychowdhuryDirector | 10,300 | — | 10,300 | Feb 26, 2019 · 6:17 pm EST | Form 4 |
| Owen HughesDirector | 10,300 | — | 10,300 | Feb 26, 2019 · 6:15 pm EST | Form 4 |
| Anthony RosenbergDirector | 10,300 | — | 10,300 | Feb 26, 2019 · 6:17 pm EST | Form 4 |
| Cathy FriedmanDirector | 10,300 | — | 10,300 | Feb 26, 2019 · 6:13 pm EST | Form 4 |
| Kurt GravesDirector | 10,300 | — | 10,300 | Feb 26, 2019 · 6:14 pm EST | Form 4 |
| Willard H DereDirector | 10,300 | — | 10,300 | Feb 26, 2019 · 6:12 pm EST | Form 4 |
| Jean Pierre GarnierDirector | 10,300 | — | 10,300 | Feb 26, 2019 · 6:13 pm EST | Form 4 |
| David P. SnowChief Commercial Officer | 6,448 | — | 6,448 | Feb 6, 2018 · 5:13 pm EST | Form 5 |
| Gary HattersleyChief Scientific Officer | 1,173 | — | 1,173 | Feb 13, 2019 · 5:33 pm EST | Form 5 |
| Lorraine A. FitzpatrickChief Medical Officer | 989 | — | 989 | Feb 13, 2019 · 5:30 pm EST | Form 5 |
| Dinesh PurandareSVP Global Oncology/Commercial | 200 | — | 200 | Sep 8, 2015 · 8:35 pm EDT | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.